Was ist die Webseite?

https://www.facebook.com/168527300321165/

Aspivix

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von Aspivix, Medizin und Gesundheit, Renens.

03/12/2025

💡 𝗪𝗼𝗻𝗱𝗲𝗿𝗶𝗻𝗴 𝗵𝗼𝘄 𝘁𝗼 𝘂𝘀𝗲 𝗰𝗮𝗿𝗲𝘃𝗶𝘅®?

We’ve got you covered. Our updated online training is here!

🎓Learn how to use carevix® confidently, support patient comfort, and make the most of your starter kit.

🎥 Watch now → https://lnkd.in/dkwr4GaJ

US: myaspivix.us
EU: myaspivix.com

hashtag hashtag hashtag hashtag hashtag hashtag hashtag Aspivix

27/11/2025

𝗪𝗲’𝗿𝗲 𝗴𝗼𝗶𝗻𝗴 𝘁𝗼 𝗕𝗮𝗿𝗰𝗲𝗹𝗼𝗻𝗮!✨

Aspivix is a finalist at Health Tech Challengers 2025 in the Women’s Health category.

Catch us pitching 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® live on stage at Health Tech Forward, December 4, 2025 with Mathieu Horras. 🚀

Big things are happening for patient-centered gynecology. Follow along as we showcase innovation and impact for women! 💜

🔗 Learn more about the event: https://healthtechforward.com/

🔗 Finalists list : https://healthtechchallengers.com/

𝗔𝘀𝗽𝗶𝘃𝗶𝘅. 𝗖𝗮𝗿𝗲, 𝗥𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗲𝗱.

26/11/2025

𝗡𝗲𝘄 𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗜𝗩𝗙 𝘄𝗶𝘁𝗵 𝘀𝘂𝗰𝗰𝗲𝘀𝘀! 💜

𝗰𝗮𝗿𝗲𝘃𝗶𝘅® goes beyond IUDs, now supporting clinicians in IVF for smoother, more comfortable embryo transfers.

We’re proud to see 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® used successfully at the renowned Juaneda Hospitales by 𝗗𝗿. 𝗙𝗲𝗹𝗶𝗽𝗲 𝗚𝗮𝗹𝗹𝗲𝗴𝗼 𝗧𝗲𝗿𝗿𝗶𝘀 and his team.

Expanding possibilities in women’s care, one innovation at a time. 💡

24/11/2025

𝗪𝗵𝗮𝘁 𝘀𝘁𝗮𝗿𝘁𝘀 𝗮𝘀 𝗮 𝘄𝗵𝗶𝘀𝗽𝗲𝗿 𝗶𝘀 𝗯𝗲𝗰𝗼𝗺𝗶𝗻𝗴 𝗮 𝗺𝗼𝘃𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝘄𝗼𝗺𝗲𝗻’𝘀 𝗰𝗮𝗿𝗲. 💜

Across Los Angeles, Orange County and New York, more and more women are asking the same question:“Why haven’t we been given better options?”

Today, we’re proud to answer.

Introducing carevix® — a breakthrough in transcervical procedures designed to reduce pain and improve comfort.

𝗧𝗵𝗶𝘀 𝗶𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻.

𝗜𝘁’𝘀 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗳𝗲𝗲𝗹.

Women deserve technology that respects their experience — and the standard of care is changing.

➡️ To learn more, visit: https://www.aspivix.com/

𝗔𝘀𝗽𝗶𝘃𝗶𝘅 - 𝗚𝘆𝗻𝗲𝗰𝗼𝗹𝗼𝗴𝘆. 𝗡𝗼𝘄 𝗠𝗼𝗱𝗲𝗿𝗻.

Aspivix

20/11/2025

🤝 𝗖𝗮𝘀𝗲 𝗦𝘁𝘂𝗱𝘆 𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁: 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝗘𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗗𝗼𝗰𝘁𝗼𝗿𝘀

🚀 Expanding into a new market takes more than just a great product — it takes trusted partnerships. To launch 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® in Germany, we teamed up with Spirit to connect with leading gynecologists and bring our solution into expert hands.

The result?

✅ 3 collaboration agreements with top KOLs

✅ Real-world insights from the field

✅ A faster, more credible market entry, because when women’s health is on the line, partnerships with purpose make all the difference. 💜

Read here for more ➡️ : https://www.peakspirit.ch/post/aspivix

19/11/2025

We are incredibly proud to share that Aspivix 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗮𝘄𝗮𝗿𝗱𝗲𝗱 𝘁𝗵𝗲 𝗦𝘁𝗲𝘄𝗮𝗿𝗱𝗴𝗮𝗿𝗱 𝗔𝘄𝗮𝗿𝗱 𝟮𝟬𝟮𝟱 𝗯𝘆 𝘁𝗵𝗲 𝗦𝘄𝗶𝘀𝘀 𝗔𝗺𝗲𝗿𝗶𝗰𝗮𝗻 𝗖𝗵𝗮𝗺𝗯𝗲𝗿 𝗼𝗳 𝗖𝗼𝗺𝗺𝗲𝗿𝗰𝗲! 💜 🏆

This recognition in Los Angeles celebrates innovation, leadership, and impact, and we’re honored that our work in compassionate, patient-centered gynecology has been distinguished among such outstanding companies.

This award reinforces our mission: to reimagine women’s healthcare with technology that puts comfort, dignity, and better experiences first.

🔗𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗔𝘃𝗮𝗻𝘁𝗴𝗮𝗿𝗱𝗲 𝗔𝘄𝗮𝗿𝗱: saccla.org/avantgarde-award-2025.html

𝗔𝘀𝗽𝗶𝘃𝗶𝘅. 𝗖𝗮𝗿𝗲, 𝗥𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗲𝗱.

17/11/2025

📢 Besuchen Sie Aspivix auf der GRSSGO Journée d’Automne 2025

Wir freuen uns, Sie vom 20. bis 21. November 2025 auf der Journée d’Automne der Groupement Romand de la Société Suisse de Gynécologie et Obstétrique (GRSSGO) in der Schweiz begrüßen zu dürfen.

👩‍⚕️ Annika Dunkel, unsere Spezialistin für klinische Anwendungen, wird an dieser Veranstaltung teilnehmen und sich an Diskussionen beteiligen, die die Gesundheitsversorgung von Frauen in der Schweiz und darüber hinaus voranbringen.

Mit carevix®, unserem CE-gekennzeichneten atraumatischen Gebärmutterhalsstabilisator, überdenken wir transzervikale Eingriffe wie die Einlage von Intrauterinpessaren – und machen sie sanfter, sicherer und respektvoller für Frauen.

Besuchen Sie uns dort und entdecken Sie carevix!

_______________________________

📢 Join Aspivix at GRSSGO Journée d’Automne 2025

We’re delighted to welcome you at the Groupement Romand de la Société Suisse de Gynécologie et Obstétrique (GRSSGO) Journée d’Automne in Switzerland on 20–21 November 2025.

👩‍⚕️ Annika Dunkel, our Clinical Application Specialist, will be attending this event, joining discussions that advance women’s healthcare in Switzerland and beyond.

With carevix®, our CE-marked atraumatic cervical stabilizer, we are rethinking transcervical procedures such as IUD insertions — making them gentler, safer, and more respectful for women.

Join us there to discover carevix!

13/11/2025

💜𝗖𝗮𝗿𝗲𝘃𝗶𝘅® 𝗶𝗻 𝗡𝘂𝗺𝗯𝗲𝗿𝘀 – 𝗥𝗲𝗮𝗹-𝗪𝗼𝗿𝗹𝗱 𝗜𝗺𝗽𝗮𝗰𝘁: A Data-Driven Look at Our Clinical, Regulatory & Market Reach

“In the quest to modernize gynecology, numbers tell the most powerful story: Less pain, more satisfaction, and real, scalable impact.”

- 𝟳𝟯% ↓ 𝗶𝗻 𝗽𝗮𝗶𝗻 & 𝟳𝟴% ↓ 𝗶𝗻 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝗱𝘂𝗿𝗶𝗻𝗴 𝗜𝗨𝗗 𝗶𝗻𝘀𝗲𝗿𝘁𝗶𝗼𝗻𝘀 (𝗔𝗗𝗩𝗔𝗡𝗖𝗘 𝗪𝗼𝗺𝗲𝗻 𝗥𝗖𝗧 𝘀𝘁𝘂𝗱𝘆)

- 𝟵𝟰% 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝘀𝗮𝘁𝗶𝘀𝗳𝗮𝗰𝘁𝗶𝗼𝗻 across transcervical procedures from over 1,250 global patients

- Regulatory approvals across U.S., EU, UK, Brazil

- 𝗡𝗮𝗺𝗲𝗱 𝗧𝗜𝗠𝗘 𝗕𝗲𝘀𝘁 𝗜𝗻𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟰 & 𝗲𝗮𝗿𝗻𝗲𝗱 𝗮𝗻 𝗶𝗙 𝗗𝗲𝘀𝗶𝗴𝗻 𝗔𝘄𝗮𝗿𝗱

“Behind every number is a woman whose experience is now less painful and more dignified. 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® isn't just a device—it’s a movement toward modern, empathetic gynecology.”

Visit → www.aspivix.com for more.

,

10/11/2025

📢 Aspivix auf dem KMS 2025

Wir freuen uns, Ihnen mitteilen zu können, dass Aspivix vom 13. bis 14. November 2025 am Kongress für praktische Gynäkologie und Geburtshilfe (KMS) in der Schweiz teilnehmen wird.

👩‍⚕️ Unsere Kollegin Annika Dunkel, klinischer Vertriebsspezialist, wird uns bei diesem wichtigen Treffen von Fachleuten aus dem Gesundheitswesen vertreten.

Bei Aspivix ist es unsere Mission, Innovation und Mitgefühl in die gynäkologische Versorgung zu bringen. Mit carevix®, CE-gekennzeichneten, atraumatischen Gebärmutterhalsstabilisator, wollen wir Eingriffe wie die Einlage von Intrauterinpessaren sanfter und schmerzarmer machen – und so die Gesundheit von Frauen mit patientenorientierten Lösungen verbessern.

Wir freuen uns darauf, Kontakte zu knüpfen, Neues zu lernen und zu Diskussionen beizutragen, die die Zukunft der Gynäkologie prägen.

Verbinden Sie sich jetzt mit Annika Dunkel ➡️ :
https://www.linkedin.com/in/annika-dunkel/

_______________________________

📢 Aspivix at the KMS 2025

We are pleased to announce that Aspivix will be participating in the Congress for Practical Gynecology and Obstetrics (KMS) in Switzerland from November 13 to 14, 2025.

👩‍⚕️ Our colleague Annika Dunkel, Clinical Sales Specialist, will represent us at this important gathering of healthcare professionals.

At Aspivix, our mission is to bring innovation and compassion to gynecological care. With carevix®, a CE-marked, atraumatic cervical stabilizer, we aim to make procedures such as intrauterine device insertion gentler and less painful—improving women's health with patient-centered solutions.

We look forward to networking, learning new things, and contributing to discussions that will shape the future of gynecology.

Connect now with Annika Dunkel➡️ :
https://www.linkedin.com/in/annika-dunkel/

06/11/2025

𝗪𝗵𝗮𝘁 𝗶𝗳 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗱𝗶𝗱𝗻’𝘁 𝗿𝗲𝗾𝘂𝗶𝗿𝗲 𝗽𝗮𝗶𝗻?

What if the tenaculum wasn’t your only option? At 𝗔𝘀𝗽𝗶𝘃𝗶𝘅, we’re redefining women’s healthcare with innovation that truly cares.💜

Our 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® device uses gentle suction-based technology to stabilize the cervix — offering a smarter, safer, and more compassionate alternative for transcervical procedures.

Healthcare professionals in Los Angeles, Orange County, and New York can now access the exclusive 𝗖𝗮𝗿𝗲𝘃𝗶𝘅® Starter Pack, available at 𝗠𝘆𝗔𝘀𝗽𝗶𝘃𝗶𝘅.𝘂𝘀 - https://myaspivix.us/

Because every woman deserves precision without pain. 💙𝗔𝘀𝗽𝗶𝘃𝗶𝘅 - 𝗖𝗮𝗿𝗲 𝗿𝗲𝗶𝗺𝗮𝗴𝗶𝗻𝗲𝗱.

05/11/2025

What if 9 out of 10 of your patients experienced less pain during procedures?

That’s exactly what healthcare providers report when using 𝗰𝗮𝗿𝗲𝘃𝗶𝘅®.

𝟵/𝟭𝟬 HCPs saw reduced patient discomfort*

𝟵𝟰% of patients were satisfied*

𝟵𝟲% of providers found 𝗰𝗮𝗿𝗲𝘃𝗶𝘅® simple and intuitive*

These aren’t just numbers. They’re real results reshaping women’s health. carevix® empowers clinicians to deliver gentler, more confident care while building stronger patient trust.

Are you ready to redefine patient comfort in your clinic?

👉 Learn more: myaspivix.us

04/11/2025

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗮𝘁 𝘁𝗵𝗲 𝗪𝗛𝗜𝗦 𝗨𝗦𝗔 𝟮𝟬𝟮𝟱 💜

Join our CMO, Ikram Guerd, at the 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗦𝘂𝗺𝗺𝗶𝘁 𝗨𝗦𝗔, where leaders and innovators come together to shape the next era of women’s health.

She will share insights on how to elevate brands in Women’s Health. For too long, discomfort during gynecological care has been accepted as “normal.” As an illustration at Aspivix, we’re changing that narrative. With carevix®, our mission is clear: to make transcervical procedures gentler, more compassionate, and pain-free, empowering both providers and patients alike.

This summit is more than an event, it’s a movement. A space where ideas meet impact, and where women’s comfort and dignity take center stage. Let’s reimagine care, together. 💫

Adresse

Webseite

facebook.com

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Aspivix erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Wollen Sie Ihr Praxis zum Top-Klinik in Renens machen?

Kategorie

Medizin und Gesundheit

ASPIVIX

ASPIVIX is a Swiss-based medical device company dedicated to R&D, Manufacturing and Sales of technologies for women’s health.

Our vision is to empower women around the world by driving healthcare innovation in areas that are needed the most, thus making a positive impact in women’s everyday life.

Our flagship product, is a next generation, patent protected vacuum-based cervical device that delivers the same manoeuvrability as the traumatic tenaculum - used 80 million times/year - without the reported patient trauma related to pain, bleeding, tissue tear. We believe that women deserve gentler and more modern methods for procedures in gynecology.

Results from “First in Women” Trial in Switzerland are expected in 2H2020.